Wednesday, October 22, 2014
Go to Market Reports.com
FabRICATOR® - perfect F(ab?)2 fragments in minutes
First siRNA Library Screening in Hard-to-Transfect HUVEC and Jurkat Ce
Knockdown of BACE-1, an Alzheimer’s Disease Drug Target, with NIMT®FeO
Measurement of Proteasome Inhibition in Live Cells in Molecular Device
NIMT®FeOfection|PURPLE in siRNA Delivery into HEK293 Cells
Nucleofection® Enables Luciferase Reporter Assays in Primary Cells and
Optimized cell culture
Tecan Group Ltd.
RNAi-mediated CD2 suppression in primary human T cells
ScreenTape® Enables Fast Quality Control of miRNA qPCR Reactions
showing results 10 to 18 of 21
New Test can Help Doctors Choose Best Treatment for Ovarian Cancer
ADNEX discriminate between benign and malignant tumours with a high level of accuracy.
All the Cell’s a Stage
Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.
New Cancer Drug To Begin Trials In Multiple Myeloma Patients
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
ISB Gets $6.5 Million from NCI
Company has received two-year contract to create ‘Cancer Genomics Cloud’ with partners Google and SRA International.
Precise Control Over Genes Results from Game-Changing Research
UCSF invention greatly amplifies power of CRISPR technology.
Unusual Skin Cancer Linked To Chronic Allergy
Scientists have learned that inflammation at the site of an allergic skin rash can promote skin tumor formation if it persists.
New Clues For Early Colorectal Cancer Detection
Study identifies new biomarkers which could help detect colorectal cancer.
New 'Lab-on-a-Chip' Could Revolutionize Early Diagnosis of Cancer
Faster result times, reduced costs, minimal sample demands and better sensitivity of analysis.
Dramatic Response And Resistance To Cancer Drug Traced
Sequencing reveals why thyroid tumor responded to, and eventually resisted, treatment.
Personalized Ovarian Cancer Vaccines
UConn Researchers have found a new way to identify protein mutations in cancer cells.
Advertise On This Site
Terms & Conditions
©2014 Technology Networks
, all rights reserved.